RHÖN-KLINIKUM Aktiengesellschaft (RHK) - Net Assets
Based on the latest financial reports, RHÖN-KLINIKUM Aktiengesellschaft (RHK) has net assets worth €1.34 Billion EUR (≈ $1.57 Billion USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€1.86 Billion ≈ $2.18 Billion USD) and total liabilities (€523.09 Million ≈ $611.55 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check RHÖN-KLINIKUM Aktiengesellschaft liquidity resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €1.34 Billion |
| % of Total Assets | 71.93% |
| Annual Growth Rate | 4.93% |
| 5-Year Change | 11.41% |
| 10-Year Change | 19.6% |
| Growth Volatility | 14.46 |
RHÖN-KLINIKUM Aktiengesellschaft - Net Assets Trend (2002–2024)
This chart illustrates how RHÖN-KLINIKUM Aktiengesellschaft's net assets have evolved over time, based on quarterly financial data. Also explore how large is RHÖN-KLINIKUM Aktiengesellschaft's balance sheet for the complete picture of this company's asset base.
Annual Net Assets for RHÖN-KLINIKUM Aktiengesellschaft (2002–2024)
The table below shows the annual net assets of RHÖN-KLINIKUM Aktiengesellschaft from 2002 to 2024. For live valuation and market cap data, see RHÖN-KLINIKUM Aktiengesellschaft market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €1.33 Billion ≈ $1.55 Billion |
+3.57% |
| 2023-12-31 | €1.28 Billion ≈ $1.50 Billion |
+2.30% |
| 2022-12-31 | €1.25 Billion ≈ $1.46 Billion |
+2.18% |
| 2021-12-31 | €1.22 Billion ≈ $1.43 Billion |
+2.90% |
| 2020-12-31 | €1.19 Billion ≈ $1.39 Billion |
+0.37% |
| 2019-12-31 | €1.19 Billion ≈ $1.39 Billion |
+2.29% |
| 2018-12-31 | €1.16 Billion ≈ $1.36 Billion |
+3.02% |
| 2017-12-31 | €1.13 Billion ≈ $1.32 Billion |
+1.07% |
| 2016-12-31 | €1.11 Billion ≈ $1.30 Billion |
+0.42% |
| 2015-12-31 | €1.11 Billion ≈ $1.30 Billion |
-11.23% |
| 2014-12-31 | €1.25 Billion ≈ $1.46 Billion |
-25.07% |
| 2013-12-31 | €1.67 Billion ≈ $1.95 Billion |
+3.68% |
| 2012-12-31 | €1.61 Billion ≈ $1.88 Billion |
+0.55% |
| 2011-12-31 | €1.60 Billion ≈ $1.87 Billion |
+6.92% |
| 2010-12-31 | €1.50 Billion ≈ $1.75 Billion |
+5.08% |
| 2009-12-31 | €1.42 Billion ≈ $1.66 Billion |
+60.01% |
| 2008-12-31 | €889.26 Million ≈ $1.04 Billion |
+15.53% |
| 2007-12-31 | €769.71 Million ≈ $899.87 Million |
+11.38% |
| 2006-12-31 | €691.10 Million ≈ $807.97 Million |
+13.44% |
| 2005-12-31 | €609.22 Million ≈ $712.24 Million |
+11.59% |
| 2004-12-31 | €545.92 Million ≈ $638.24 Million |
+7.42% |
| 2003-12-31 | €508.19 Million ≈ $594.13 Million |
+10.49% |
| 2002-12-31 | €459.94 Million ≈ $537.72 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to RHÖN-KLINIKUM Aktiengesellschaft's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 51.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €554.43 Million | 42.78% |
| Common Stock | €167.41 Million | 12.92% |
| Other Components | €574.09 Million | 44.30% |
| Total Equity | €1.30 Billion | 100.00% |
RHÖN-KLINIKUM Aktiengesellschaft Competitors by Market Cap
The table below lists competitors of RHÖN-KLINIKUM Aktiengesellschaft ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Sirio Pharma
SHE:300791
|
$876.92 Million |
|
Cybrid Technologies Inc
SHG:603212
|
$877.06 Million |
|
UNITIL Corporation
NYSE:UTL
|
$877.29 Million |
|
MilDef Group AB
ST:MILDEF
|
$877.30 Million |
|
Indian Metals & Ferro Alloys Limited
NSE:IMFA
|
$876.76 Million |
|
Anhui Huilong Agricultural Means of Production Co Ltd
SHE:002556
|
$876.74 Million |
|
Cowealth Medical China Co.Ltd.
SHG:603122
|
$876.63 Million |
|
Zhejiang Zomax Transmission
SHG:603767
|
$876.60 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in RHÖN-KLINIKUM Aktiengesellschaft's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,252,040,000 to 1,295,930,000, a change of 43,890,000 (3.5%).
- Net income of 43,351,000 contributed positively to equity growth.
- Other comprehensive income decreased equity by 178,168,000.
- Other factors increased equity by 178,707,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €43.35 Million | +3.35% |
| Other Comprehensive Income | €-178.17 Million | -13.75% |
| Other Changes | €178.71 Million | +13.79% |
| Total Change | €- | 3.51% |
Book Value vs Market Value Analysis
This analysis compares RHÖN-KLINIKUM Aktiengesellschaft's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.64x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.03x to 0.64x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | €12.03 | €12.40 | x |
| 2003-12-31 | €13.65 | €12.40 | x |
| 2004-12-31 | €15.29 | €12.40 | x |
| 2005-12-31 | €5.69 | €12.40 | x |
| 2006-12-31 | €6.45 | €12.40 | x |
| 2007-12-31 | €7.19 | €12.40 | x |
| 2008-12-31 | €8.58 | €12.40 | x |
| 2009-12-31 | €9.96 | €12.40 | x |
| 2010-12-31 | €10.56 | €12.40 | x |
| 2011-12-31 | €11.25 | €12.40 | x |
| 2012-12-31 | €11.45 | €12.40 | x |
| 2013-12-31 | €11.90 | €12.40 | x |
| 2014-12-31 | €9.38 | €12.40 | x |
| 2015-12-31 | €15.10 | €12.40 | x |
| 2016-12-31 | €16.29 | €12.40 | x |
| 2017-12-31 | €16.47 | €12.40 | x |
| 2018-12-31 | €16.96 | €12.40 | x |
| 2019-12-31 | €17.35 | €12.40 | x |
| 2020-12-31 | €17.41 | €12.40 | x |
| 2021-12-31 | €17.90 | €12.40 | x |
| 2022-12-31 | €18.28 | €12.40 | x |
| 2023-12-31 | €18.70 | €12.40 | x |
| 2024-12-31 | €19.36 | €12.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently RHÖN-KLINIKUM Aktiengesellschaft utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 3.35%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.72%
- • Asset Turnover: 0.86x
- • Equity Multiplier: 1.43x
- Recent ROE (3.35%) is below the historical average (12.17%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 17.50% | 8.54% | 0.88x | 2.34x | €32.19 Million |
| 2003 | 16.35% | 8.33% | 0.86x | 2.28x | €30.96 Million |
| 2004 | 14.00% | 7.31% | 0.90x | 2.12x | €21.81 Million |
| 2005 | 13.74% | 5.91% | 0.87x | 2.66x | €22.76 Million |
| 2006 | 15.22% | 5.44% | 0.98x | 2.86x | €36.09 Million |
| 2007 | 13.81% | 5.25% | 0.98x | 2.69x | €29.32 Million |
| 2008 | 13.79% | 5.76% | 1.00x | 2.41x | €33.72 Million |
| 2009 | 9.57% | 5.67% | 0.81x | 2.08x | €-5.96 Million |
| 2010 | 9.94% | 5.69% | 0.83x | 2.10x | €-818.90K |
| 2011 | 10.04% | 5.94% | 0.83x | 2.04x | €615.90K |
| 2012 | 5.67% | 3.13% | 0.90x | 2.01x | €-68.50 Million |
| 2013 | 5.27% | 2.88% | 0.97x | 1.88x | €-77.85 Million |
| 2014 | 99.77% | 81.15% | 0.84x | 1.47x | €1.10 Billion |
| 2015 | 7.85% | 7.70% | 0.68x | 1.50x | €-23.42 Million |
| 2016 | 5.17% | 4.80% | 0.81x | 1.34x | €-52.63 Million |
| 2017 | 3.19% | 2.90% | 0.82x | 1.33x | €-75.08 Million |
| 2018 | 4.32% | 3.97% | 0.78x | 1.40x | €-64.54 Million |
| 2019 | 3.73% | 3.32% | 0.80x | 1.41x | €-72.87 Million |
| 2020 | 0.12% | 0.11% | 0.83x | 1.40x | €-115.08 Million |
| 2021 | 2.36% | 2.02% | 0.84x | 1.39x | €-91.54 Million |
| 2022 | 2.05% | 1.74% | 0.85x | 1.39x | €-97.24 Million |
| 2023 | 3.09% | 2.23% | 0.98x | 1.41x | €-86.49 Million |
| 2024 | 3.35% | 2.72% | 0.86x | 1.43x | €-86.24 Million |
Industry Comparison
This section compares RHÖN-KLINIKUM Aktiengesellschaft's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $5,863,591,555
- Average return on equity (ROE) among peers: -73.98%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| RHÖN-KLINIKUM Aktiengesellschaft (RHK) | €1.34 Billion | 17.50% | 0.39x | $876.89 Million |
| China Resources Medical Holdings Company Limited (1PH) | $7.01 Billion | 3.67% | 0.95x | $428.88 Million |
| AEST.MED.INT.HLD.SP.ADR/3 (3FMA) | $-125.88 Million | 0.00% | 0.00x | $3.30 Million |
| JINXIN FERT.GRP HD-00001 (3NX) | $10.35 Billion | 2.73% | 0.45x | $720.78 Million |
| REVITALIST L.A.W. LTD (4DO) | $1.87 Million | -771.24% | 4.54x | $744.60K |
| Wenzhou Kangning Hospital Co. Ltd (4WK) | $1.34 Billion | 4.88% | 1.24x | $19.18 Million |
| Bumrungrad Hospital Public Company Limited (BZ7A) | $24.10 Billion | 29.08% | 0.21x | $49.31K |
| Eifelhöhen-Klinik AG (EIF) | $9.88 Million | -19.11% | 6.64x | $8.99 Million |
| Fresenius Medical Care AG & Co. KGaA (FME) | $2.01 Billion | -12.28% | 1.84x | $12.02 Billion |
| Fresenius Medical Care AG & Co. KGaA (FMEA) | $10.83 Billion | 11.82% | 1.22x | $11.58 Billion |
| Fresenius SE & Co. KGaA (FRE) | $3.10 Billion | 10.64% | 3.84x | $27.16 Billion |
About RHÖN-KLINIKUM Aktiengesellschaft
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, provides in-patient, semi-patient, and outpatient healthcare services in Germany. The company also operates acute hospitals, medical care centers, and rehabilitation hospitals. RHÖN-KLINIKUM Aktiengesellschaft was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.